PM decides to provide financial support for COVIVAC vaccine trials
Hanoi (VNA) – The Prime Minister has decided to use
over 8.8 billion VND from the national COVID-19 vaccine fund to support the
first and second phase of clinical trials of COVIVAC vaccine, which has been developed
by the Health Ministry’s Institute of Vaccines and Medical
Biologicals (IVAC) since May 2020.
COVIVAC uses viral vector technology on primary
chicken embryo cell culture - a technique IVAC used previously to successfully
produce seasonal flu vaccines. It is preserved at temperatures from 2-8 degrees
Celsius.
In the first phase, it was evaluated as safe,
well-tolerant and immunogenic.
The second phase will be carried out in Vu Thu district, northern Thai
Binh province, with 375 volunteers.
COVIVAC is the second “made-in-Vietnam” vaccine to be allowed
for clinical trials by the Health Ministry, following Nanogen company’s
NanoCovax./.